BR9810495A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR9810495A
BR9810495A BR9810495-0A BR9810495A BR9810495A BR 9810495 A BR9810495 A BR 9810495A BR 9810495 A BR9810495 A BR 9810495A BR 9810495 A BR9810495 A BR 9810495A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
cyclodextrin
family
pharmaceutical compositions
oral administration
Prior art date
Application number
BR9810495-0A
Other languages
English (en)
Inventor
Domenico Fanara
Monique Berwaer
Philippe Nolf
Henri Vranckx
Michel Deleers Belga
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3890611&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9810495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of BR9810495A publication Critical patent/BR9810495A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

<B>"COMPOSIçãO FARMACêUTICA"<D>. A presente invenção refere-se a composições farmacêuticas que podem ser administradas por via oral compreendendo uma substância ativa que pertence à família das benzidrilpiperazinas substituídas e pelo menos uma ciclodextrina.
BR9810495-0A 1997-07-03 1998-07-02 Composição farmacêutica BR9810495A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700572A BE1011251A3 (fr) 1997-07-03 1997-07-03 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
PCT/BE1998/000100 WO1999001133A1 (fr) 1997-07-03 1998-07-02 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine

Publications (1)

Publication Number Publication Date
BR9810495A true BR9810495A (pt) 2000-09-12

Family

ID=3890611

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810495-0A BR9810495A (pt) 1997-07-03 1998-07-02 Composição farmacêutica

Country Status (21)

Country Link
US (1) US6455533B1 (pt)
EP (1) EP0994710B2 (pt)
JP (2) JP2002508773A (pt)
KR (1) KR100551510B1 (pt)
CN (1) CN1150900C (pt)
AT (1) ATE224717T1 (pt)
AU (1) AU727140B2 (pt)
BE (1) BE1011251A3 (pt)
BR (1) BR9810495A (pt)
CA (1) CA2294783C (pt)
DE (1) DE69808297T3 (pt)
DK (1) DK0994710T4 (pt)
ES (1) ES2184293T5 (pt)
HK (1) HK1029060A1 (pt)
ID (1) ID23806A (pt)
IL (1) IL133397A (pt)
NZ (1) NZ501820A (pt)
PL (1) PL192348B1 (pt)
PT (1) PT994710E (pt)
RU (1) RU2192863C2 (pt)
WO (1) WO1999001133A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
WO2002062320A1 (en) * 2001-02-05 2002-08-15 R.P. Scherer Technologies, Inc. Methods and compositions for reducing the taste of pharmaceutically active agents
KR101005648B1 (ko) * 2002-01-15 2011-01-05 유씨비 파쉼 소시에떼아노님 제형
JP2005526104A (ja) * 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
EP2178521B1 (en) * 2007-07-11 2014-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
WO2009006899A1 (en) * 2007-07-11 2009-01-15 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US8138192B2 (en) * 2007-10-31 2012-03-20 Genebiology, Inc. Injectable meclizine formulations and methods
US20090137606A1 (en) * 2007-11-06 2009-05-28 Rakefet Cohen Chewable formulations
AU2009288006B2 (en) * 2008-09-05 2014-07-17 Mcneil-Ppc, Inc. Method for making cetirizine tablets
WO2011110939A2 (en) * 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
WO2011150859A1 (en) * 2010-06-04 2011-12-08 Comprehensive Drug Enterprises Ltd Oral meclizine aqueous formulations with taste flavoring agent
CN101905027A (zh) * 2010-07-27 2010-12-08 北京华禧联合科技发展有限公司 含米格列奈钙和环糊精的口服药用组合物
CA2811202A1 (en) 2010-09-13 2012-03-22 Bev-Rx, Inc. Aqueous drug delivery system comprising off-flavor masking agent
US9945862B2 (en) 2011-06-03 2018-04-17 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
RU2589833C2 (ru) * 2013-12-12 2016-07-10 Общество С Ограниченной Ответственностью "Фарма Старт" Твердая лекарственная форма препарата седативного и снотворного действия
PL3122330T3 (pl) * 2014-03-27 2019-01-31 Ucb Farchim, S.A. Kompozycje farmaceutyczne zawierające lewocetyryzynę
EP4089076A1 (en) 2014-08-28 2022-11-16 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
CA2976325C (en) 2015-02-25 2023-07-04 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
KR20180018695A (ko) 2015-06-16 2018-02-21 가부시키가이샤 프리즘 파마 항암제
KR102110304B1 (ko) * 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
US20230414597A1 (en) 2020-11-18 2023-12-28 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JPS60204712A (ja) * 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS63243031A (ja) † 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
DE69320975T2 (de) † 1992-09-24 1999-05-12 Sepracor Inc Verwendung von (-) Cetirizin zur Behandlung allergischer Rhinitis und und Asthma
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Also Published As

Publication number Publication date
ID23806A (id) 2000-05-11
WO1999001133A1 (fr) 1999-01-14
HK1029060A1 (en) 2001-03-23
EP0994710A1 (fr) 2000-04-26
NZ501820A (en) 2000-10-27
US6455533B1 (en) 2002-09-24
EP0994710B1 (fr) 2002-09-25
IL133397A0 (en) 2001-04-30
KR20010014398A (ko) 2001-02-26
DE69808297D1 (de) 2002-10-31
JP2007091760A (ja) 2007-04-12
DK0994710T3 (da) 2003-01-20
IL133397A (en) 2005-07-25
JP2002508773A (ja) 2002-03-19
RU2192863C2 (ru) 2002-11-20
PL337794A1 (en) 2000-09-11
PT994710E (pt) 2003-02-28
ATE224717T1 (de) 2002-10-15
AU8201598A (en) 1999-01-25
CN1150900C (zh) 2004-05-26
EP0994710B2 (fr) 2005-09-21
KR100551510B1 (ko) 2006-02-13
DE69808297T2 (de) 2003-04-17
CA2294783A1 (fr) 1999-01-14
AU727140B2 (en) 2000-12-07
CA2294783C (fr) 2006-11-14
US20020032217A1 (en) 2002-03-14
CN1261799A (zh) 2000-08-02
DK0994710T4 (da) 2005-10-17
ES2184293T3 (es) 2003-04-01
ES2184293T5 (es) 2006-01-16
PL192348B1 (pl) 2006-10-31
DE69808297T3 (de) 2006-01-19
BE1011251A3 (fr) 1999-06-01

Similar Documents

Publication Publication Date Title
BR9810495A (pt) Composição farmacêutica
BG106030A (en) Pharmaceutical composition
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
BR0015188A (pt) Composições farmacêuticas
IT1255258B (it) Composizioni farmaceutiche per l&#39;applicazione per via nasale.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
BR9611802A (pt) Composições farmacêuticas
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
AU2845599A (en) Pharmaceutical compositions and their use
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
DE69908375D1 (de) Nimesulide-haltige topische arzneimittel
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE OS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: UCB FARCHIM S.A. (CH)

Free format text: TRANSFERIDO DE: UCB, S.A.